GI Insights

By ReachMD

What's GI Insights about?

Looking to digest the latest in gastroenterology? GI Insights is here to provide updates on screening guidelines, diagnostic options, and management tools for all diseases and disorders affecting the gastrointestinal tract.

Download our free app to listen on your phone

GI Insights episodes:

04.15.2024
Managing Extraintestinal Manifestations in IBD
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Katherine Falloon, MD Extraintestinal manifestations (EIMs) that occur in inflammatory bowel disease (IBD) are almost any manifestation that occur outside the gastrointestinal tract. And...
03.28.2024
How Artificial Intelligence Is Changing the Practice of Gastroenterology
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Ali Soroush, MD, MS Due to recent technological advancements, the use of artificial intelligence to detect a variety of gastroenterological conditions like Barrett’s esophagus,...
03.05.2024
Solutions for Defeating the Negative Impacts of Refractory Constipation
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Joy Liu, MD For patients with refractory constipation, it’s important to evaluate the psychological impact of these symptoms. Unfortunately, this disorder can easily affect...
$Solutions for Defeating the Negative Impacts of Refractory Constipation$
03.04.2024
Progressing Towards Post-ERCP Pancreatitis Prevention
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Prabhleen Chahal, MD Post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis is the most dreaded complication of this procedure. So what are the patient-related, procedure-related, and operator-related...
02.29.2024
Perianal Crohn’s Disease: The Importance of Multidisciplinary Management
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Benjamin L. Cohen, MD Guest: Stefan Holubar, MD, MS Affecting over 25 percent of Crohn's disease patients, perianal disease is a persistent...
02.27.2024
Addressing Alcohol-Associated Liver Disease and Sobriety Pathways
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Paul Kwo, MD In patients with chronic live disease, consuming alcohol could contribute to progressive liver damage and a variety of cancers. So alcohol...
02.23.2024
Reviewing Updated Guidelines and Knowledge Gaps for Pouchitis Management
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Edward L. Barnes, MD, MPH Pouchitis is a common inflammatory complication after ileal pouch-anal anastomosis (J-pouch) surgery, but the why behind patients who develop...
02.22.2024
Addressing the Unique Cases of Portal Vein Thrombosis
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Shilpa Junna, MD Symptoms of portal vein thrombosis (PVT) are primarily driven by the extent of the obstruction that the PVT is causing, and...
02.15.2024
Exploring New Developments in the Treatment of Recurrent C. Difficile
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Paul Feuerstadt MD, FACG, AGAF C. difficile is a major problem in the United States. On top of that, patients who are diagnosed with...
02.12.2024
The Spectrum of Liver Transplantation: Addressing the Needs of Diverse Patient Groups
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Michael Lucey, MD There are a lot of considerations to keep in mind when it comes to liver transplantation in patients with various diseases,...
02.06.2024
Harnessing the Power of Social Media in GI
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Benjamin Schmidt, MD It’s become clear that social media is here to stay, and it’s become a way that people get their information and...
02.06.2024
The Role of Antibiotics in Acute Uncomplicated Appendicitis Treatment
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: David Talan, MD Until recently, surgery was always utilized for appendicitis, but now, antibiotics are an alternative treatment. Find out who the best candidates...
01.22.2024
Postoperative Recurrence of Crohn‘s Disease: Reviewing Monitoring and Treatment Strategies
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Miguel Regueiro, MD There are a few factors that may predict patients who are more likely to experience postoperative recurrence of Crohn’s disease. So...
01.19.2024
Assessing IBD with Intestinal Ultrasound and Exploring Ongoing Research
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: David T. Rubin, MD Intestinal ultrasound has become a useful tool in assessing disease progression and pathophysiology of inflammatory bowel disease (IBD). It’s an...
11.21.2023
Hope on the Horizon: The Evaluation and Treatment of Fecal Incontinence
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Kyle Staller, MD, MPH Unfortunately, there are not a lot of specific pharmacologic agents for incontinent patients; however, using typical antidiarrheal therapies can be...
11.21.2023
The Updated Role of Non-Invasive Biomarkers in MASLD
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Julia J Wattacheril, MD, MPH Non-invasive biomarkers for metabolic dysfunction-associated steatosis liver disease (MASLD) are used to stratify risk and assess disease severity in...
11.15.2023
Colorectal Cancer in Young Patients: A Multidisciplinary Approach
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: David Liska, MD Since the 1990s, clinicians have been seeing a significant increase in colorectal cancer among young patients, who are under the age...
10.24.2023
The Use of Anticoagulants and Antiplatelet Medications in Cirrhosis
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Naga Chalasani, MD With the increasing incidence and prevalence of cirrhosis in patients, healthcare professionals have to routinely consider giving anticoagulants to these patients....
10.10.2023
Managing Liver Disease in Diabetic Patients: A Comprehensive Approach to Care
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Michael Charlton, MD Liver disease is highly prevalent in patients with type 2 diabetes, and it’s much more likely to be a clinically significant...
10.05.2023
Learning About the New Definition of MASLD
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Paul Kwo, MD Non-alcoholic fatty liver disease connoted that there's no alcohol contribution to the fat and didn't accurately convey the interplay between metabolic-driven...
10.03.2023
The Increasing Incidence of IBD and the Use of Biosimilars
Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Shubha Bhat, PharmD Fortunately, there are a lot of studies that have evaluated biosimilars in inflammatory bowel disease (IBD), and those all confirmed...
09.26.2023
Distinguishing Digestive Disorders: How to ID Non-Celiac Gluten Sensitivity
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Marianna Arvanitakis, MD, PhD Patients with non-celiac gluten sensitivity can experience the same symptoms of those with celiac disease and IBS, complicating the diagnostic...
09.26.2023
10 Recommendations for Managing CIC
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: William Chey, MD Roughly 1 in 10 Americans suffer with some degree of constipation, and many of those patients suffer with ongoing chronic issues...
09.07.2023
Reviewing Cardiac Complications in Liver Disease
Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Zobair M Younossi MD, MPH, FACP, FACG, AGAF, FAASLD Guest: Alan H.B. Wu, PhD Liver disease patients are at an increased risk of...
08.16.2023
Personalizing Care to Fit GERD Patient Needs
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: John Pandolfino, MD, MSCI There are a wide range of therapeutic options when it comes to personalizing your patient’s treatment approach, such as simple...
08.07.2023
How to Recognize & Manage an Angry Patient
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Douglas Drossman, MD We all face angry and disruptive patients from time to time, making it essential to know how to properly de-escalate and...
08.03.2023
Biomarkers for Ulcerative Colitis Management: A Review of the AGA Guidelines
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Siddharth Singh, MD How can we use biomarkers to treat patients with ulcerative colitis? That’s the exact question the latest guideline from the American...
08.02.2023
A Look into Liver Transplants
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Alan Bonder, MD According to the United Network for Organ Sharing (UNOS), more than 95 percent of patients are alive and doing well after...
07.31.2023
Reviewing Best Practices for Endoscopic Ultrasound
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Kunal Jajoo, MD The American Gastroenterological Association (AGA) recently published updated clinical guidelines for the use of endoscopic ultrasound (EUS). Are there caveats involved...
07.31.2023
Disease Spotlight: Reflecting on Liver Health in Diabetes Care
Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Suijit Janardhan, MD, PhD Diabetic patients have a significant risk for developing more advanced liver disease, and the disease that they’re particularly at risk for...
07.26.2023
Updates on the Diagnosis & Management of AHP
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Herbert L. Bonkovsky, MD If an elevation of delta aminolevulinic or porphobilinogen occurs in the urine more than three times what is normal, that...
07.19.2023
Treatment Strategies for Nonalcoholic Fatty Liver Disease: Part 2
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Sidney Barritt, MD Even though nonalcoholic fatty liver disease is the most common form of chronic liver disease in the United States, there are...
07.19.2023
Treatment Strategies for Nonalcoholic Fatty Liver Disease: Part 1
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Sidney Barritt, MD Even though nonalcoholic fatty liver disease is the most common form of chronic liver disease in the United States, there are...
07.14.2023
Ultra-Processed Food Consumption: What Are the Risks?
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Marianna Arvanitakis, MD, PhD Consuming ultra-processed foods can pose many risks to your health that go beyond the GI system. Explore the risks associated...
07.13.2023
Diagnosing & Managing Celiac Disease: Reviewing Updated Recommendations
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Claire Jansson-Knodell, MD When a person has a low IgA level, the tissue transglutaminase immunoglobulin A antibody is no longer a useful screening test...
06.05.2023
Addressing the Challenges of Gastroparesis in Patients
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Michael Camilleri, MD Metoclopramide is the only FDA-approved medication for the treatment of gastroparesis; however, it comes with a black box warning. To discuss...
06.01.2023
Identifying Individualized Treatment Approaches for EOE Patients
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Brooks D. Cash, MD, AGAF, FACG, FACP, FASGE Assessing eosinophilic esophagitis (EOE) patients’ sensitivity to specific foods is key to creating a personalized diet...
06.01.2023
Uncovering the Complications of Primary Biliary Cholangitis
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Alan Bonder, MD According to this clinician, the most important thing for primary biliary cholangitis (PBC) patients is the diagnosis, and anyone with abnormal...
05.05.2023
Uncovering Unmet Needs in Hepatitis Management
Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Paul Kwo, MD Hepatitis B and C are both highly prevalent infections around the world. However, many individuals are not aware of their infection, which...
04.28.2023
Strategies for Optimizing Liver Health in Diabetic Patients
Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Scott D. Isaacs, MD FACP, FACE Since type 2 diabetes is the number one risk factor for the progression to advanced liver fibrosis,...
04.20.2023
The Role of Treatments & Endoscopy in the Anticoagulated Patient
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Kunal Jajoo, MD Clinicians should be assessing their patients immediately and trying to understand how quickly they need to provide endoscopy and endoscopic therapy....
04.19.2023
A Review of Autoimmune Hepatitis in Patients
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Alan Bonder, MD Patients with underlying autoimmune diseases could be at a higher risk of developing autoimmune hepatitis (AIH). So what challenges might occur...
04.18.2023
Managing Patients with Lower Gastrointestinal Bleeding
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Neil Sengupta, MD Lower GI bleeding is one of the most common reasons that patients are hospitalized due to a digestive disorder in the...
04.18.2023
Addressing Treatment Challenges in Hepatitis D Patients
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Robert Wong, MD There may be benefit in testing all hepatitis B patients for hepatitis D, such as reducing the risk of disease progression...
04.12.2023
Reviewing a Vibrating Capsule for Chronic Constipation
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Eamonn Quigley, MD A new treatment option may help relieve chronic constipation in patients who might not respond well to traditional therapies. To learn...
03.29.2023
Assessing New Guidelines for Hepatocellular Carcinoma
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Amit Singal, MD, MS Hepatocellular carcinoma (HCC) is the most common type of liver cancer and most often occurs in people with chronic liver...
03.29.2023
Reviewing Management Strategies for Barrett’s Esophagus & EAC
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Joel Rubenstein, M.D., M.Sc. Gastroesophageal reflux disease (GERD) is an important risk factor for Barrett’s esophagus and esophageal adenocarcinoma (EAC), but there are other...
02.27.2023
Exploring Updates in the C. Difficile Treatment Landscape
Host: Neilanjan Nandi, MD Guest: Monika Fischer, MD Clostridioides difficile, or C. difficile for short, is a bacteria that continues to plague our patients. What are the latest treatment updates that you...
02.24.2023
An Overview of Ogilvie’s Syndrome: Key Diagnostic & Therapeutic Considerations
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Brooks D. Cash, MD, AGAF, FACG, FACP, FASGE Acute colonic pseudo-obstruction, also known as Ogilvie’s syndrome, is a rare form of colonic dilatation that...
02.22.2023
Tips on Technology-Enabled Solutions for GI Patients
Host: Neilanjan Nandi, MD Guest: Megan E. Riehl, PsyD In an age where there’s an app for everything, are smartphone apps and other technology-enable solutions revolutionizing mental health treatment in patients with...

What's GI Insights about?

Download our free app to listen on your phone

GI Insights episodes:

Managing Extraintestinal Manifestations in IBD

How Artificial Intelligence Is Changing the Practice of Gastroenterology

Solutions for Defeating the Negative Impacts of Refractory Constipation

Progressing Towards Post-ERCP Pancreatitis Prevention

Perianal Crohn’s Disease: The Importance of Multidisciplinary Management

Addressing Alcohol-Associated Liver Disease and Sobriety Pathways

Reviewing Updated Guidelines and Knowledge Gaps for Pouchitis Management

Addressing the Unique Cases of Portal Vein Thrombosis

Exploring New Developments in the Treatment of Recurrent C. Difficile

The Spectrum of Liver Transplantation: Addressing the Needs of Diverse Patient Groups

Harnessing the Power of Social Media in GI

The Role of Antibiotics in Acute Uncomplicated Appendicitis Treatment

Postoperative Recurrence of Crohn‘s Disease: Reviewing Monitoring and Treatment Strategies

Assessing IBD with Intestinal Ultrasound and Exploring Ongoing Research

Hope on the Horizon: The Evaluation and Treatment of Fecal Incontinence

The Updated Role of Non-Invasive Biomarkers in MASLD

Colorectal Cancer in Young Patients: A Multidisciplinary Approach

The Use of Anticoagulants and Antiplatelet Medications in Cirrhosis

Managing Liver Disease in Diabetic Patients: A Comprehensive Approach to Care

Learning About the New Definition of MASLD

The Increasing Incidence of IBD and the Use of Biosimilars

Distinguishing Digestive Disorders: How to ID Non-Celiac Gluten Sensitivity

10 Recommendations for Managing CIC

Reviewing Cardiac Complications in Liver Disease

Personalizing Care to Fit GERD Patient Needs

How to Recognize & Manage an Angry Patient

Biomarkers for Ulcerative Colitis Management: A Review of the AGA Guidelines

A Look into Liver Transplants

Reviewing Best Practices for Endoscopic Ultrasound

Disease Spotlight: Reflecting on Liver Health in Diabetes Care

Updates on the Diagnosis & Management of AHP

Treatment Strategies for Nonalcoholic Fatty Liver Disease: Part 2

Treatment Strategies for Nonalcoholic Fatty Liver Disease: Part 1

Ultra-Processed Food Consumption: What Are the Risks?

Diagnosing & Managing Celiac Disease: Reviewing Updated Recommendations

Addressing the Challenges of Gastroparesis in Patients

Identifying Individualized Treatment Approaches for EOE Patients

Uncovering the Complications of Primary Biliary Cholangitis

Uncovering Unmet Needs in Hepatitis Management

Strategies for Optimizing Liver Health in Diabetic Patients

The Role of Treatments & Endoscopy in the Anticoagulated Patient

A Review of Autoimmune Hepatitis in Patients

Managing Patients with Lower Gastrointestinal Bleeding

Addressing Treatment Challenges in Hepatitis D Patients

Reviewing a Vibrating Capsule for Chronic Constipation

Assessing New Guidelines for Hepatocellular Carcinoma

Reviewing Management Strategies for Barrett’s Esophagus & EAC

Exploring Updates in the C. Difficile Treatment Landscape

An Overview of Ogilvie’s Syndrome: Key Diagnostic & Therapeutic Considerations

Tips on Technology-Enabled Solutions for GI Patients